Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination
•LAIV3 induced age-related hemagglutination inhibition antibody responses.•IgG1 was the main IgG subclass detected followed by IgG3.•Significant hemagglutinin-specific IgG1 and IgA1 response in children but not adults.•LAIV3 and IIV3 induced IgG antibodies with comparable and significantly increased...
Saved in:
Published in | Vaccine Vol. 35; no. 1; pp. 191 - 198 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
03.01.2017
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0264-410X 1873-2518 |
DOI | 10.1016/j.vaccine.2016.10.024 |
Cover
Abstract | •LAIV3 induced age-related hemagglutination inhibition antibody responses.•IgG1 was the main IgG subclass detected followed by IgG3.•Significant hemagglutinin-specific IgG1 and IgA1 response in children but not adults.•LAIV3 and IIV3 induced IgG antibodies with comparable and significantly increased avidity.
Two different influenza vaccines are generally used in many countries; trivalent live attenuated influenza vaccine (LAIV3) and trivalent inactivated influenza vaccine (IIV3). Studies comparing the antibody response to IIV3 and LAIV3 commonly investigate the seroprotective response by hemagglutination-inhibition (HI) assay. However, there is limited data regarding comparative analysis of IgG subclass and IgA responses induced by LAIV3 and IIV3.
Fifteen children <5years received 2 doses of LAIV3 while 14 children aged 10–17years received one dose. In addition, 15 adults were vaccinated with either intranasal LAIV3 or intramuscular IIV3. We analyzed the H3N2 humoral responses by HI assay and the hemagglutinin (HA) specific IgG1, IgG2, IgG3, IgG4 and IgA1 responses by ELISA. Furthermore, we investigated the avidity of induced IgG antibodies.
Pre-existing seroprotective HI antibodies were present in adults (73%) previously vaccinated with IIV3. Vaccination resulted in a significant increase in HI titers in all groups, except LAIV3 vaccinated adults. Furthermore, a negative correlation between age and HI titers in LAIV3 vaccinated subjects was observed post-vaccination. LAIV3 in children and IIV3 in adults induced HA-specific IgG1, low IgG3 but no IgG2 or IgG4. Moreover, significant IgA1 responses were only induced in children. Interestingly, IIV3 and LAIV3 induced IgG antibodies with comparable and significantly augmented avidity post-vaccination in children and adults.
Our results suggest that age and/or exposure history play a significant role in determining the antibody response.
Clinical trial registry: ClinicalTrials.gov NCT01003288 and NCT01866540 |
---|---|
AbstractList | Two different influenza vaccines are generally used in many countries; trivalent live attenuated influenza vaccine (LAIV3) and trivalent inactivated influenza vaccine (IIV3). Studies comparing the antibody response to IIV3 and LAIV3 commonly investigate the seroprotective response by hemagglutination-inhibition (HI) assay. However, there is limited data regarding comparative analysis of IgG subclass and IgA responses induced by LAIV3 and IIV3.Fifteen children <5years received 2 doses of LAIV3 while 14 children aged 10–17years received one dose. In addition, 15 adults were vaccinated with either intranasal LAIV3 or intramuscular IIV3. We analyzed the H3N2 humoral responses by HI assay and the hemagglutinin (HA) specific IgG1, IgG2, IgG3, IgG4 and IgA1 responses by ELISA. Furthermore, we investigated the avidity of induced IgG antibodies.Pre-existing seroprotective HI antibodies were present in adults (73%) previously vaccinated with IIV3. Vaccination resulted in a significant increase in HI titers in all groups, except LAIV3 vaccinated adults. Furthermore, a negative correlation between age and HI titers in LAIV3 vaccinated subjects was observed post-vaccination. LAIV3 in children and IIV3 in adults induced HA-specific IgG1, low IgG3 but no IgG2 or IgG4. Moreover, significant IgA1 responses were only induced in children. Interestingly, IIV3 and LAIV3 induced IgG antibodies with comparable and significantly augmented avidity post-vaccination in children and adults.Our results suggest that age and/or exposure history play a significant role in determining the antibody response.Clinical trial registry: ClinicalTrials.gov NCT01003288 and NCT01866540 Two different influenza vaccines are generally used in many countries; trivalent live attenuated influenza vaccine (LAIV3) and trivalent inactivated influenza vaccine (IIV3). Studies comparing the antibody response to IIV3 and LAIV3 commonly investigate the seroprotective response by hemagglutination-inhibition (HI) assay. However, there is limited data regarding comparative analysis of IgG subclass and IgA responses induced by LAIV3 and IIV3. Fifteen children <5years received 2 doses of LAIV3 while 14 children aged 10-17years received one dose. In addition, 15 adults were vaccinated with either intranasal LAIV3 or intramuscular IIV3. We analyzed the H3N2 humoral responses by HI assay and the hemagglutinin (HA) specific IgG1, IgG2, IgG3, IgG4 and IgA1 responses by ELISA. Furthermore, we investigated the avidity of induced IgG antibodies. Pre-existing seroprotective HI antibodies were present in adults (73%) previously vaccinated with IIV3. Vaccination resulted in a significant increase in HI titers in all groups, except LAIV3 vaccinated adults. Furthermore, a negative correlation between age and HI titers in LAIV3 vaccinated subjects was observed post-vaccination. LAIV3 in children and IIV3 in adults induced HA-specific IgG1, low IgG3 but no IgG2 or IgG4. Moreover, significant IgA1 responses were only induced in children. Interestingly, IIV3 and LAIV3 induced IgG antibodies with comparable and significantly augmented avidity post-vaccination in children and adults. Our results suggest that age and/or exposure history play a significant role in determining the antibody response. Clinical trial registry: ClinicalTrials.gov NCT01003288 and NCT01866540. •LAIV3 induced age-related hemagglutination inhibition antibody responses.•IgG1 was the main IgG subclass detected followed by IgG3.•Significant hemagglutinin-specific IgG1 and IgA1 response in children but not adults.•LAIV3 and IIV3 induced IgG antibodies with comparable and significantly increased avidity. Two different influenza vaccines are generally used in many countries; trivalent live attenuated influenza vaccine (LAIV3) and trivalent inactivated influenza vaccine (IIV3). Studies comparing the antibody response to IIV3 and LAIV3 commonly investigate the seroprotective response by hemagglutination-inhibition (HI) assay. However, there is limited data regarding comparative analysis of IgG subclass and IgA responses induced by LAIV3 and IIV3. Fifteen children <5years received 2 doses of LAIV3 while 14 children aged 10–17years received one dose. In addition, 15 adults were vaccinated with either intranasal LAIV3 or intramuscular IIV3. We analyzed the H3N2 humoral responses by HI assay and the hemagglutinin (HA) specific IgG1, IgG2, IgG3, IgG4 and IgA1 responses by ELISA. Furthermore, we investigated the avidity of induced IgG antibodies. Pre-existing seroprotective HI antibodies were present in adults (73%) previously vaccinated with IIV3. Vaccination resulted in a significant increase in HI titers in all groups, except LAIV3 vaccinated adults. Furthermore, a negative correlation between age and HI titers in LAIV3 vaccinated subjects was observed post-vaccination. LAIV3 in children and IIV3 in adults induced HA-specific IgG1, low IgG3 but no IgG2 or IgG4. Moreover, significant IgA1 responses were only induced in children. Interestingly, IIV3 and LAIV3 induced IgG antibodies with comparable and significantly augmented avidity post-vaccination in children and adults. Our results suggest that age and/or exposure history play a significant role in determining the antibody response. Clinical trial registry: ClinicalTrials.gov NCT01003288 and NCT01866540 Highlights • LAIV3 induced age-related hemagglutination inhibition antibody responses. • IgG1 was the main IgG subclass detected followed by IgG3. • Significant hemagglutinin-specific IgG1 and IgA1 response in children but not adults. • LAIV3 and IIV3 induced IgG antibodies with comparable and significantly increased avidity. |
Author | Manenti, Alessandro Cox, Rebecca J. Tete, Sarah M. Mohn, Kristin G.-I. Brokstad, Karl A. Gianchecchi, Elena Jul-Larsen, Åsne Montomoli, Emanuele |
Author_xml | – sequence: 1 givenname: Alessandro surname: Manenti fullname: Manenti, Alessandro organization: Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy – sequence: 2 givenname: Sarah M. surname: Tete fullname: Tete, Sarah M. email: sarah.tete@uib.no organization: The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway – sequence: 3 givenname: Kristin G.-I. surname: Mohn fullname: Mohn, Kristin G.-I. organization: The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway – sequence: 4 givenname: Åsne surname: Jul-Larsen fullname: Jul-Larsen, Åsne organization: The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway – sequence: 5 givenname: Elena surname: Gianchecchi fullname: Gianchecchi, Elena organization: VisMederi Srl, Siena, Italy – sequence: 6 givenname: Emanuele surname: Montomoli fullname: Montomoli, Emanuele organization: Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy – sequence: 7 givenname: Karl A. surname: Brokstad fullname: Brokstad, Karl A. organization: Broegelman Research Laboratory, Department of Clinical Sciences, University of Bergen, Bergen, Norway – sequence: 8 givenname: Rebecca J. surname: Cox fullname: Cox, Rebecca J. email: rebecca.cox@uib.no organization: The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27789145$$D View this record in MEDLINE/PubMed |
BookMark | eNqNklFv0zAQxy00xLrCRwBZ4mU8pNhO7CRCA1UVbJMmeAAk3izHuXQurhPspFL3SfZxcdZOoEqoPFk-_-5_57v_GTpxrQOEXlIyo4SKt6vZRmltHMxYvMbYjLDsCZrQIk8TxmlxgiaEiSzJKPlxis5CWBFCeErLZ-iU5XlR0oxP0P2iXXfKq95sACun7DaYgNsGG9fYAdydwvPzq_Qze4M3xg8B38JaLZd26I0zDocOtGmMxtfLSxyGSlsVQtSpY2COPYSudQFCVMP61tjag3t4VfVg-wg2Pfi_Su2-FJtp3XP0tFE2wIv9OUXfP338trhKbr5cXi_mN4kWlPcJF7WqqiZLC100RBFBFGM6z1Utilo0vCqzQnDOYrDUFeM54UwzylSjhVClSqfofKfb-fbXAKGXaxM0WKsctEOQLE6NcZby_ChKSyIyXgqRHUeLlIu4gWJEXx-gq3bwcRMjlYmCsjLSU_RqTw3VGmrZebNWfisfNxmBdztA-zYED43Upn-YZO-VsZISOfpGruTeN3L0zRiOvonZ_CD7scCxvA-7PIgr2hjwMmgDTkNtPOhe1q05qvD-QEHbaC2t7E_YQvgzCxmYJPLr6OnR0lSkpMxIGQUu_i3wHw38BgMYCT8 |
CitedBy_id | crossref_primary_10_3201_eid2502_180359 crossref_primary_10_1093_jpids_piad033 crossref_primary_10_1371_journal_pone_0244157 crossref_primary_10_1021_acs_jproteome_1c00913 crossref_primary_10_1073_pnas_2216521120 crossref_primary_10_1038_s41598_022_18977_0 crossref_primary_10_1080_14760584_2020_1711056 crossref_primary_10_3390_vaccines9090998 crossref_primary_10_1016_j_jim_2020_112937 crossref_primary_10_1371_journal_pone_0247253 crossref_primary_10_1093_cid_ciz774 crossref_primary_10_1097_MOP_0000000000001438 crossref_primary_10_1002_cti2_1456 crossref_primary_10_1016_j_antiviral_2024_105823 crossref_primary_10_1111_irv_12664 crossref_primary_10_1128_mBio_02281_16 crossref_primary_10_1016_j_vaccine_2021_12_034 crossref_primary_10_1016_j_vaccine_2017_08_044 crossref_primary_10_1038_s41577_019_0143_6 crossref_primary_10_15789_1563_0625_AOT_2737 crossref_primary_10_1155_2022_4813199 crossref_primary_10_4049_jimmunol_2400326 |
Cites_doi | 10.1007/s10875-010-9501-7 10.1093/infdis/154.1.121 10.1086/515656 10.1016/j.jim.2015.04.009 10.1016/j.vaccine.2010.10.038 10.1086/315003 10.1146/annurev.biochem.69.1.531 10.1097/01.inf.0000237829.66310.85 10.1093/infdis/jit207 10.1371/journal.ppat.1004940 10.1016/S0264-410X(99)00334-5 10.1016/j.cyto.2012.08.004 10.1093/cid/cit736 10.1099/0022-1317-82-6-1387 10.1016/j.vaccine.2008.07.013 10.1016/j.vaccine.2015.05.081 10.1016/j.vaccine.2012.09.018 10.1016/S0264-410X(00)00171-7 10.1016/j.jaci.2009.09.046 10.1086/517407 10.1016/S1386-6532(01)00246-3 10.1128/IAI.40.3.1044-1051.1983 10.1016/j.vaccine.2014.06.009 10.1016/j.vaccine.2005.08.105 10.1128/JCM.23.1.66-72.1986 10.1128/JCM.24.1.157-160.1986 10.1016/S0022-3476(00)70097-7 10.1186/1742-4933-10-14 10.4049/jimmunol.178.2.1030 10.1093/infdis/171.1.198 10.1586/eri.11.51 10.1016/j.vaccine.2007.02.039 10.1093/infdis/jis641 10.1111/j.1365-2249.2011.04550.x 10.1097/01.inf.0000237797.14283.cf 10.7883/yoken.JJID.2004.236 10.1111/ajt.13065 |
ContentType | Journal Article |
Copyright | 2016 The Authors The Authors Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved. Copyright Elsevier Limited Jan 3, 2017 |
Copyright_xml | – notice: 2016 The Authors – notice: The Authors – notice: Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved. – notice: Copyright Elsevier Limited Jan 3, 2017 |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 7S9 L.6 |
DOI | 10.1016/j.vaccine.2016.10.024 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Collection (ProQuest) Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Consumer Health Database ProQuest Health & Medical Collection Healthcare Administration Database Medical Database ProQuest Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE Research Library Prep |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-2518 |
EndPage | 198 |
ExternalDocumentID | 4272457301 27789145 10_1016_j_vaccine_2016_10_024 S0264410X16309409 1_s2_0_S0264410X16309409 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACVFH ADBBV ADCNI ADEZE ADFRT AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEUYN AEVXI AEXOQ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGGSO AGUBO AGYEJ AHMBA AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO Q38 ROL RPZ SAB SCC SDF SDG SDP SES SNL SPCBC SSH SSI SSZ T5K UKHRP UV1 WH7 WOW Z5R ~G- .GJ 29Q 3V. AACTN AAQXK ABWVN ABXDB ACRPL ADMUD ADNMO ADVLN AFCTW AFJKZ AFKWA AGHFR AHHHB AJOXV ALIPV AMFUW ASPBG AVWKF AZFZN FEDTE FGOYB G-2 HEJ HLV HMG HMK HMO HVGLF HX~ HZ~ R2- RIG SAE SEW SIN SVS WUQ XPP ZGI ZXP 6I. AAFTH AAIAV ABLVK ABYKQ AESVU AJBFU EFLBG LCYCR QYZTP AAYXX ACMHX ADSLC AGQPQ AGRNS AGWPP AIGII CITATION CGR CUY CVF ECM EIF NPM 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-c615t-56dabbf438c8f0a060a22c77ad68d6f5b948655222c9cb257052c212afc66a9a3 |
IEDL.DBID | AIKHN |
ISSN | 0264-410X |
IngestDate | Fri Sep 05 09:58:19 EDT 2025 Fri Sep 05 03:47:44 EDT 2025 Thu Sep 04 17:33:10 EDT 2025 Wed Aug 13 09:21:19 EDT 2025 Thu Apr 03 07:01:22 EDT 2025 Tue Jul 01 01:06:32 EDT 2025 Thu Apr 24 22:58:48 EDT 2025 Fri Feb 23 02:21:13 EST 2024 Tue Feb 25 20:08:49 EST 2025 Tue Aug 26 16:38:07 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Live attenuated influenza vaccine IgA LAIV3 Influenza IgG subclass Antibody response |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c615t-56dabbf438c8f0a060a22c77ad68d6f5b948655222c9cb257052c212afc66a9a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0264410X16309409 |
PMID | 27789145 |
PQID | 1846812918 |
PQPubID | 105530 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2000252357 proquest_miscellaneous_1906459664 proquest_miscellaneous_1835691484 proquest_journals_1846812918 pubmed_primary_27789145 crossref_citationtrail_10_1016_j_vaccine_2016_10_024 crossref_primary_10_1016_j_vaccine_2016_10_024 elsevier_sciencedirect_doi_10_1016_j_vaccine_2016_10_024 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X16309409 elsevier_clinicalkey_doi_10_1016_j_vaccine_2016_10_024 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-01-03 |
PublicationDateYYYYMMDD | 2017-01-03 |
PublicationDate_xml | – month: 01 year: 2017 text: 2017-01-03 day: 03 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: Kidlington |
PublicationTitle | Vaccine |
PublicationTitleAlternate | Vaccine |
PublicationYear | 2017 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | Pedersen, Hoschler, Oie Solbak, Bredholt, Pathirana, Afsar (b0085) 2014; 32 Organization WH. Influenza (seasonal) factsheet 211; 2014. Available from Edwards, Dimmock (b0105) 2001; 82 Boyce, Hsu, Sannella, Coleman-Dockery, Baylis, Zhu (b0175) 2000; 19 Johnson, Feldman, Thompson, Mahoney, Wright (b0185) 1986; 154 Clements, O’Donnell, Levine, Chanock, Murphy (b0095) 1983; 40 El-Madhun, Cox, Haaheim (b0070) 1999; 180 Belshe, Gruber, Mendelman, Cho, Reisinger, Block (b0155) 2000; 136 Goodwin, Viboud, Simonsen (b0020) 2006; 24 Powell, Strutt, Reome, Hollenbaugh, Roberts, Woodland (b0140) 2007; 178 Katz, Hancock, Xu (b0035) 2011; 9 Stepanova, Naykhin, Kolmskog, Jonson, Barantceva, Bichurina (b0115) 2002; 24 Fleming, Crovari, Wahn, Klemola, Schlesinger, Langussis (b0130) 2006; 25 Ambrose, Wu, Jones, Mallory (b0150) 2012; 30 Treanor, Kotloff, Betts, Belshe, Newman, Iacuzio (b0135) 1999; 18 Clements, Murphy (b0100) 1986; 23 Clements, Betts, Tierney, Murphy (b0055) 1986 Jul; 24 Ramakrishnan, Althoff, Lopez, Coles, Bream (b0010) 2012; 60 Frasca, Blomberg (b0120) 2011; 31 Tamura, Kurata (b0075) 2004; 57 Ohmit, Thompson, Petrie, Thaker, Jackson, Belongia (b0025) 2014; 58 Barria, Garrido, Stein, Scher, Ge, Engel (b0180) 2013; 207 Schild, Pereira, Chakraverty (b0040) 1975; 52 el-Madhun, Cox, Soreide, Olofsson, Haaheim (b0170) 1998; 178 . Mohn, Bredholt, Brokstad, Pathirana, Aarstad, Tondel (b0190) 2014; 25 Frasca, Diaz, Romero, Mendez, Landin, Blomberg (b0030) 2013; 10 Skehel, Wiley (b0110) 2000; 69 Goldblatt, Vaz, Miller (b0195) 1998 Apr; 177 Schroeder, Cavacini (b0065) 2010; 125 Ashkenazi, Vertruyen, Aristegui, Esposito, McKeith, Klemola (b0125) 2006; 25 Block, Yogev, Hayden, Ambrose, Zeng, Walker (b0160) 2008; 26 Eidem, Tete, Jul-Larsen, Hoschler, Montomoli, Brokstad (b0200) 2015; 33 Crum-Cianflone, Collins, Defang, Iverson, Eberly, Duplessis (b0060) 2012; 168 Grohskopf, Olsen, Sokolow, Bresee, Cox, Broder (b0090) 2014; 14 Meyer, Wilke (b0005) 2015; 11 Brokstad, Cox, Olofsson, Jonsson, Haaheim (b0165) 1995; 171 Trombetta, Perini, Vitale, Cox, Stanzani, Piccirella (b0045) 2015; 422 Cheng, Zengel, Suguitan, Xu, Wang, Lin (b0145) 2013; 208 Stephenson, Das, Wood, Katz (b0050) 2007; 25 Madhun, Akselsen, Sjursen, Pedersen, Svindland, Nostbakken (b0080) 2010; 29 Johnson (10.1016/j.vaccine.2016.10.024_b0185) 1986; 154 Clements (10.1016/j.vaccine.2016.10.024_b0055) 1986; 24 Belshe (10.1016/j.vaccine.2016.10.024_b0155) 2000; 136 Eidem (10.1016/j.vaccine.2016.10.024_b0200) 2015; 33 Brokstad (10.1016/j.vaccine.2016.10.024_b0165) 1995; 171 Barria (10.1016/j.vaccine.2016.10.024_b0180) 2013; 207 Frasca (10.1016/j.vaccine.2016.10.024_b0030) 2013; 10 Ashkenazi (10.1016/j.vaccine.2016.10.024_b0125) 2006; 25 Clements (10.1016/j.vaccine.2016.10.024_b0100) 1986; 23 Stephenson (10.1016/j.vaccine.2016.10.024_b0050) 2007; 25 Madhun (10.1016/j.vaccine.2016.10.024_b0080) 2010; 29 Ramakrishnan (10.1016/j.vaccine.2016.10.024_b0010) 2012; 60 Frasca (10.1016/j.vaccine.2016.10.024_b0120) 2011; 31 Meyer (10.1016/j.vaccine.2016.10.024_b0005) 2015; 11 Tamura (10.1016/j.vaccine.2016.10.024_b0075) 2004; 57 Ohmit (10.1016/j.vaccine.2016.10.024_b0025) 2014; 58 Mohn (10.1016/j.vaccine.2016.10.024_b0190) 2014; 25 Trombetta (10.1016/j.vaccine.2016.10.024_b0045) 2015; 422 Pedersen (10.1016/j.vaccine.2016.10.024_b0085) 2014; 32 Grohskopf (10.1016/j.vaccine.2016.10.024_b0090) 2014; 14 Boyce (10.1016/j.vaccine.2016.10.024_b0175) 2000; 19 Goodwin (10.1016/j.vaccine.2016.10.024_b0020) 2006; 24 Cheng (10.1016/j.vaccine.2016.10.024_b0145) 2013; 208 Treanor (10.1016/j.vaccine.2016.10.024_b0135) 1999; 18 Powell (10.1016/j.vaccine.2016.10.024_b0140) 2007; 178 Ambrose (10.1016/j.vaccine.2016.10.024_b0150) 2012; 30 Block (10.1016/j.vaccine.2016.10.024_b0160) 2008; 26 Schroeder (10.1016/j.vaccine.2016.10.024_b0065) 2010; 125 Katz (10.1016/j.vaccine.2016.10.024_b0035) 2011; 9 Crum-Cianflone (10.1016/j.vaccine.2016.10.024_b0060) 2012; 168 Edwards (10.1016/j.vaccine.2016.10.024_b0105) 2001; 82 El-Madhun (10.1016/j.vaccine.2016.10.024_b0070) 1999; 180 10.1016/j.vaccine.2016.10.024_b0015 Goldblatt (10.1016/j.vaccine.2016.10.024_b0195) 1998; 177 Clements (10.1016/j.vaccine.2016.10.024_b0095) 1983; 40 Skehel (10.1016/j.vaccine.2016.10.024_b0110) 2000; 69 Schild (10.1016/j.vaccine.2016.10.024_b0040) 1975; 52 Stepanova (10.1016/j.vaccine.2016.10.024_b0115) 2002; 24 Fleming (10.1016/j.vaccine.2016.10.024_b0130) 2006; 25 el-Madhun (10.1016/j.vaccine.2016.10.024_b0170) 1998; 178 |
References_xml | – volume: 60 start-page: 661 year: 2012 end-page: 666 ident: b0010 article-title: Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines publication-title: Cytokine – volume: 69 start-page: 531 year: 2000 end-page: 569 ident: b0110 article-title: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin publication-title: Annu Rev Biochem – volume: 31 start-page: 430 year: 2011 end-page: 435 ident: b0120 article-title: Aging affects human B cell responses publication-title: J Clin Immunol – volume: 10 start-page: 14 year: 2013 ident: b0030 article-title: Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011–2012 influenza vaccine season publication-title: Immun Ageing – volume: 19 start-page: 217 year: 2000 end-page: 226 ident: b0175 article-title: Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults publication-title: Vaccine – volume: 178 start-page: 1030 year: 2007 end-page: 1038 ident: b0140 article-title: Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus publication-title: J Immunol – volume: 40 start-page: 1044 year: 1983 end-page: 1051 ident: b0095 article-title: Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus publication-title: Infect Immun – volume: 82 start-page: 1387 year: 2001 end-page: 1395 ident: b0105 article-title: A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity publication-title: J Gen Virol – volume: 178 start-page: 933 year: 1998 ident: b0170 article-title: Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination publication-title: J Infect Dis – volume: 32 start-page: 4550 year: 2014 end-page: 4557 ident: b0085 article-title: Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination publication-title: Vaccine – volume: 30 start-page: 6794 year: 2012 end-page: 6801 ident: b0150 article-title: The role of nasal IgA in children vaccinated with live attenuated influenza vaccine publication-title: Vaccine – volume: 25 year: 2014 ident: b0190 article-title: Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children publication-title: J Infect Dis – volume: 207 start-page: 115 year: 2013 end-page: 124 ident: b0180 article-title: Localized mucosal response to intranasal live attenuated influenza vaccine in adults publication-title: J Infect Dis – volume: 24 start-page: 157 year: 1986 Jul end-page: 160 ident: b0055 article-title: Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus publication-title: J Clin Microbiol – volume: 180 start-page: 1356 year: 1999 ident: b0070 article-title: The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination publication-title: J Infect Dis – volume: 24 start-page: 1159 year: 2006 ident: b0020 article-title: Antibody response to influenza vaccination in the elderly: a quantitative review publication-title: Vaccine – volume: 25 start-page: 4056 year: 2007 end-page: 4063 ident: b0050 article-title: Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study publication-title: Vaccine – volume: 136 start-page: 168 year: 2000 end-page: 175 ident: b0155 article-title: Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine publication-title: J Pediatr – volume: 11 start-page: e1004940 year: 2015 ident: b0005 article-title: Geometric constraints dominate the antigenic evolution of influenza H3N2 hemagglutinin publication-title: PLoS Pathog – volume: 171 start-page: 198 year: 1995 ident: b0165 article-title: Parenteral influenza vaccination induces a rapid systemic and local immune response publication-title: J Infect Dis – volume: 57 start-page: 236 year: 2004 ident: b0075 article-title: Defense mechanisms against influenza virus infection in the respiratory tract mucosa publication-title: Jpn J Infect Dis – volume: 25 start-page: 870 year: 2006 end-page: 879 ident: b0125 article-title: Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections publication-title: Pediatr Infect Dis J – volume: 26 start-page: 4940 year: 2008 end-page: 4946 ident: b0160 article-title: Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 publication-title: Vaccine – volume: 9 start-page: 669 year: 2011 end-page: 683 ident: b0035 article-title: Serologic assays for influenza surveillance, diagnosis and vaccine evaluation publication-title: Expert Rev Anti-Infect – volume: 154 start-page: 121 year: 1986 end-page: 127 ident: b0185 article-title: Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine publication-title: J Infect Dis – volume: 25 start-page: 860 year: 2006 end-page: 869 ident: b0130 article-title: Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma publication-title: Pediatr Infect Dis J – volume: 52 start-page: 1 year: 1975 ident: b0040 article-title: Single-radial-haemolysis: a new method for the assay of antibody to influenza haemagglutinin: applications for diagnosis and seroepidemiologic surveillance of influenza publication-title: Bull World Health Organ – volume: 29 start-page: 266 year: 2010 end-page: 273 ident: b0080 article-title: An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers publication-title: Vaccine – reference: Organization WH. Influenza (seasonal) factsheet 211; 2014. Available from: – volume: 177 start-page: 1112 year: 1998 Apr end-page: 1115 ident: b0195 article-title: Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization publication-title: J Infect Dis – volume: 14 start-page: 2906 year: 2014 end-page: 2913 ident: b0090 article-title: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2014–15 influenza season publication-title: Am J Transplant – volume: 125 start-page: S41 year: 2010 end-page: S52 ident: b0065 article-title: Structure and function of immunoglobulins publication-title: J Allergy Clin Immunol – volume: 23 start-page: 66 year: 1986 end-page: 72 ident: b0100 article-title: Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine publication-title: J Clin Microbiol – volume: 24 start-page: 193 year: 2002 end-page: 201 ident: b0115 article-title: The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly publication-title: J Clin Virol – reference: . – volume: 58 start-page: 319 year: 2014 end-page: 327 ident: b0025 article-title: Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates publication-title: Clin Infect Dis – volume: 33 start-page: 4146 year: 2015 end-page: 4154 ident: b0200 article-title: Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations publication-title: Vaccine – volume: 168 start-page: 135 year: 2012 end-page: 141 ident: b0060 article-title: Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults publication-title: Clin Exp Immunol – volume: 18 start-page: 899 year: 1999 end-page: 906 ident: b0135 article-title: Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses publication-title: Vaccine – volume: 208 start-page: 594 year: 2013 end-page: 602 ident: b0145 article-title: Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets publication-title: J Infect Dis – volume: 422 start-page: 95 year: 2015 end-page: 101 ident: b0045 article-title: Validation of Single Radial Haemolysis assay: a reliable method to measure antibodies against influenza viruses publication-title: J Immunol Methods – volume: 31 start-page: 430 issue: 3 year: 2011 ident: 10.1016/j.vaccine.2016.10.024_b0120 article-title: Aging affects human B cell responses publication-title: J Clin Immunol doi: 10.1007/s10875-010-9501-7 – volume: 154 start-page: 121 issue: 1 year: 1986 ident: 10.1016/j.vaccine.2016.10.024_b0185 article-title: Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine publication-title: J Infect Dis doi: 10.1093/infdis/154.1.121 – volume: 178 start-page: 933 issue: 4 year: 1998 ident: 10.1016/j.vaccine.2016.10.024_b0170 article-title: Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination publication-title: J Infect Dis doi: 10.1086/515656 – volume: 422 start-page: 95 issue: July year: 2015 ident: 10.1016/j.vaccine.2016.10.024_b0045 article-title: Validation of Single Radial Haemolysis assay: a reliable method to measure antibodies against influenza viruses publication-title: J Immunol Methods doi: 10.1016/j.jim.2015.04.009 – volume: 29 start-page: 266 issue: 2 year: 2010 ident: 10.1016/j.vaccine.2016.10.024_b0080 article-title: An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers publication-title: Vaccine doi: 10.1016/j.vaccine.2010.10.038 – volume: 180 start-page: 1356 issue: 4 year: 1999 ident: 10.1016/j.vaccine.2016.10.024_b0070 article-title: The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination publication-title: J Infect Dis doi: 10.1086/315003 – volume: 69 start-page: 531 year: 2000 ident: 10.1016/j.vaccine.2016.10.024_b0110 article-title: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin publication-title: Annu Rev Biochem doi: 10.1146/annurev.biochem.69.1.531 – volume: 25 start-page: 870 issue: 10 year: 2006 ident: 10.1016/j.vaccine.2016.10.024_b0125 article-title: Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections publication-title: Pediatr Infect Dis J doi: 10.1097/01.inf.0000237829.66310.85 – volume: 208 start-page: 594 issue: 4 year: 2013 ident: 10.1016/j.vaccine.2016.10.024_b0145 article-title: Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets publication-title: J Infect Dis doi: 10.1093/infdis/jit207 – volume: 11 start-page: e1004940 issue: 5 year: 2015 ident: 10.1016/j.vaccine.2016.10.024_b0005 article-title: Geometric constraints dominate the antigenic evolution of influenza H3N2 hemagglutinin publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1004940 – volume: 18 start-page: 899 issue: 9–10 year: 1999 ident: 10.1016/j.vaccine.2016.10.024_b0135 article-title: Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses publication-title: Vaccine doi: 10.1016/S0264-410X(99)00334-5 – volume: 60 start-page: 661 issue: 3 year: 2012 ident: 10.1016/j.vaccine.2016.10.024_b0010 article-title: Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines publication-title: Cytokine doi: 10.1016/j.cyto.2012.08.004 – volume: 58 start-page: 319 issue: 3 year: 2014 ident: 10.1016/j.vaccine.2016.10.024_b0025 article-title: Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates publication-title: Clin Infect Dis doi: 10.1093/cid/cit736 – volume: 82 start-page: 1387 issue: June year: 2001 ident: 10.1016/j.vaccine.2016.10.024_b0105 article-title: A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity publication-title: J Gen Virol doi: 10.1099/0022-1317-82-6-1387 – volume: 26 start-page: 4940 issue: 38 year: 2008 ident: 10.1016/j.vaccine.2016.10.024_b0160 article-title: Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49years of age publication-title: Vaccine doi: 10.1016/j.vaccine.2008.07.013 – volume: 33 start-page: 4146 issue: 33 year: 2015 ident: 10.1016/j.vaccine.2016.10.024_b0200 article-title: Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations publication-title: Vaccine doi: 10.1016/j.vaccine.2015.05.081 – volume: 30 start-page: 6794 issue: 48 year: 2012 ident: 10.1016/j.vaccine.2016.10.024_b0150 article-title: The role of nasal IgA in children vaccinated with live attenuated influenza vaccine publication-title: Vaccine doi: 10.1016/j.vaccine.2012.09.018 – volume: 19 start-page: 217 issue: 2–3 year: 2000 ident: 10.1016/j.vaccine.2016.10.024_b0175 article-title: Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults publication-title: Vaccine doi: 10.1016/S0264-410X(00)00171-7 – volume: 125 start-page: S41 issue: 2 year: 2010 ident: 10.1016/j.vaccine.2016.10.024_b0065 article-title: Structure and function of immunoglobulins publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2009.09.046 – volume: 52 start-page: 1 issue: 1 year: 1975 ident: 10.1016/j.vaccine.2016.10.024_b0040 article-title: Single-radial-haemolysis: a new method for the assay of antibody to influenza haemagglutinin: applications for diagnosis and seroepidemiologic surveillance of influenza publication-title: Bull World Health Organ – volume: 177 start-page: 1112 issue: 4 year: 1998 ident: 10.1016/j.vaccine.2016.10.024_b0195 article-title: Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization publication-title: J Infect Dis doi: 10.1086/517407 – volume: 24 start-page: 193 issue: 3 year: 2002 ident: 10.1016/j.vaccine.2016.10.024_b0115 article-title: The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly publication-title: J Clin Virol doi: 10.1016/S1386-6532(01)00246-3 – volume: 40 start-page: 1044 issue: 3 year: 1983 ident: 10.1016/j.vaccine.2016.10.024_b0095 article-title: Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus publication-title: Infect Immun doi: 10.1128/IAI.40.3.1044-1051.1983 – volume: 32 start-page: 4550 issue: 35 year: 2014 ident: 10.1016/j.vaccine.2016.10.024_b0085 article-title: Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination publication-title: Vaccine doi: 10.1016/j.vaccine.2014.06.009 – volume: 24 start-page: 1159 issue: 8 year: 2006 ident: 10.1016/j.vaccine.2016.10.024_b0020 article-title: Antibody response to influenza vaccination in the elderly: a quantitative review publication-title: Vaccine doi: 10.1016/j.vaccine.2005.08.105 – volume: 23 start-page: 66 issue: 1 year: 1986 ident: 10.1016/j.vaccine.2016.10.024_b0100 article-title: Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine publication-title: J Clin Microbiol doi: 10.1128/JCM.23.1.66-72.1986 – volume: 24 start-page: 157 issue: 1 year: 1986 ident: 10.1016/j.vaccine.2016.10.024_b0055 article-title: Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus publication-title: J Clin Microbiol doi: 10.1128/JCM.24.1.157-160.1986 – volume: 136 start-page: 168 issue: 2 year: 2000 ident: 10.1016/j.vaccine.2016.10.024_b0155 article-title: Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine publication-title: J Pediatr doi: 10.1016/S0022-3476(00)70097-7 – volume: 10 start-page: 14 issue: 1 year: 2013 ident: 10.1016/j.vaccine.2016.10.024_b0030 article-title: Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011–2012 influenza vaccine season publication-title: Immun Ageing doi: 10.1186/1742-4933-10-14 – volume: 178 start-page: 1030 issue: 2 year: 2007 ident: 10.1016/j.vaccine.2016.10.024_b0140 article-title: Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus publication-title: J Immunol doi: 10.4049/jimmunol.178.2.1030 – volume: 171 start-page: 198 year: 1995 ident: 10.1016/j.vaccine.2016.10.024_b0165 article-title: Parenteral influenza vaccination induces a rapid systemic and local immune response publication-title: J Infect Dis doi: 10.1093/infdis/171.1.198 – volume: 9 start-page: 669 issue: 6 year: 2011 ident: 10.1016/j.vaccine.2016.10.024_b0035 article-title: Serologic assays for influenza surveillance, diagnosis and vaccine evaluation publication-title: Expert Rev Anti-Infect doi: 10.1586/eri.11.51 – volume: 25 start-page: 4056 issue: 20 year: 2007 ident: 10.1016/j.vaccine.2016.10.024_b0050 article-title: Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study publication-title: Vaccine doi: 10.1016/j.vaccine.2007.02.039 – volume: 207 start-page: 115 issue: 1 year: 2013 ident: 10.1016/j.vaccine.2016.10.024_b0180 article-title: Localized mucosal response to intranasal live attenuated influenza vaccine in adults publication-title: J Infect Dis doi: 10.1093/infdis/jis641 – ident: 10.1016/j.vaccine.2016.10.024_b0015 – volume: 168 start-page: 135 issue: 1 year: 2012 ident: 10.1016/j.vaccine.2016.10.024_b0060 article-title: Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2011.04550.x – volume: 25 start-page: 860 issue: 10 year: 2006 ident: 10.1016/j.vaccine.2016.10.024_b0130 article-title: Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma publication-title: Pediatr Infect Dis J doi: 10.1097/01.inf.0000237797.14283.cf – volume: 57 start-page: 236 issue: 6 year: 2004 ident: 10.1016/j.vaccine.2016.10.024_b0075 article-title: Defense mechanisms against influenza virus infection in the respiratory tract mucosa publication-title: Jpn J Infect Dis doi: 10.7883/yoken.JJID.2004.236 – volume: 14 start-page: 2906 issue: 12 year: 2014 ident: 10.1016/j.vaccine.2016.10.024_b0090 article-title: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2014–15 influenza season publication-title: Am J Transplant doi: 10.1111/ajt.13065 – volume: 25 issue: November year: 2014 ident: 10.1016/j.vaccine.2016.10.024_b0190 article-title: Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children publication-title: J Infect Dis |
SSID | ssj0005319 |
Score | 2.3286202 |
Snippet | •LAIV3 induced age-related hemagglutination inhibition antibody responses.•IgG1 was the main IgG subclass detected followed by IgG3.•Significant... Highlights • LAIV3 induced age-related hemagglutination inhibition antibody responses. • IgG1 was the main IgG subclass detected followed by IgG3. •... Two different influenza vaccines are generally used in many countries; trivalent live attenuated influenza vaccine (LAIV3) and trivalent inactivated influenza... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 191 |
SubjectTerms | Administration, Intranasal Adolescent Adult adults Age Age Factors Allergy and Immunology antibodies Antibodies, Viral - blood Antibody Affinity Antibody Formation Antibody response Child Child, Preschool children Enzyme-Linked Immunosorbent Assay Female Health care Hemagglutination Inhibition Tests Hemagglutinin Glycoproteins, Influenza Virus - immunology hemagglutinins Humans humoral immunity IgA IgG subclass Immunization immunoglobulin A Immunoglobulin A - blood immunoglobulin G Immunoglobulin G - blood Immunoglobulins Infections Influenza Influenza A virus Influenza A Virus, H3N2 Subtype - immunology Influenza Vaccines - administration & dosage Influenza Vaccines - immunology Injections, Intramuscular LAIV3 Live attenuated influenza vaccine Male Medical personnel Middle Aged Regulatory approval Studies vaccination Vaccines Vaccines, Attenuated - administration & dosage Vaccines, Attenuated - immunology Vaccines, Inactivated - administration & dosage Vaccines, Inactivated - immunology viruses Young Adult |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Rb9MwELZgCMTLBAVGxkBGQhNIS5fEjpM8oWpiFKRNk9hQ3izHiatOKB1NO2n8En4ud46T8MA6XmOfHeXO58_x3XeEvEu1TnihmG-YMD5nUeWrWJW-MYqrMi0EszyzJ6diesG_5nHufrg1Lqyy84nWUZcLjf_ID-EkglRZWZh-vPrpY9UovF11JTTukweWugzsOcmTIcSD2cIecMzgPg-DfMjgObwcXyuNV9cY3SXGGOAV8dv2ptuwp92Djp-QbQce6aTV9lNyr6pH5GFbTvJmRB6duIvyEdk_aympbw7o-ZBh1RzQfXo2kFWDzOg7xsPYpFzaiT8jv48GUnCqHG8JXRg6b2ua_FJ08n7KTqMP9Hq-XDcUqV9nM7Tiel5TTN_EECT6ZfaZNutCI0SHcUp4MKHLNiy3amA02iWT21ZLBgIdsW75X1O139Ca0HNycfzp_GjquxoOvgastPJjUaqiMJylOjWBCkSgokgniSpFWgoTFxnH1FhAKTrTBZbUiyMN26kyWgiVKfaCbNWLunpJKPgWoUVWccMFD0OlitSkQVKUgAhZwJVHeKc9qR3BOdbZ-CG7SLZL6ZQuUen4GJTukXEvdtUyfNwlIDrTkF36KjhcCXvQXYLJvwSrxrmNRoayiWQgvwUWpgY5gGXkN8w8kvaSDhm1iOd_Jt3rrFcO8_SLySNv-2ZwLHhbpOpqscY-LBYZnJb5hj4Z0h3CiXlDH8wFi2JkVfLITrt6-u8cJUkKU8S7m1_yFXkcIZqy0X97ZGu1XFevAQuuijd2wf8BVrle0w priority: 102 providerName: ProQuest |
Title | Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X16309409 https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X16309409 https://dx.doi.org/10.1016/j.vaccine.2016.10.024 https://www.ncbi.nlm.nih.gov/pubmed/27789145 https://www.proquest.com/docview/1846812918 https://www.proquest.com/docview/1835691484 https://www.proquest.com/docview/1906459664 https://www.proquest.com/docview/2000252357 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELa2TiBeEBQYhYGMhCaQlja1Hcd5LNVGB1pVwYb6ZjlOXHVC6dS0k8YDfwd_Lnf50YBgG-IliZy7uLWduy_y3XeEvFbWhiI23HNcOk9wlnomMInnnBEmUbHkBc_syViOzsSHaTDdIsM6FwbDKivbX9r0wlpXLb1qNHsX83nvs1_4cn8KiAJJ4KJtssN4JIMW2RkcfxyNm0gPXtT3QHkPFZpEnt5599JY3MHGIC_ZxTgvJq5zUddB0MIVHT0g9ysMSQflz3xIttKsTe6UVSWv2uTuSbVf3ib7k5KZ-uqAnjaJVvkB3aeThrMadNpfMCymyM2ltfoj8mPYcINTU9GX0IWj87K0yTdDB29GfMze0sv5cp1TZICdzXAxZ_OMYhYnRiLR49l7mq9ji0gdnpNAw4Auy-jcNIen0TqnvLhbcIKAIJYv_6WrcgyLlfSYnB0dng5HXlXKwbMAmVZeIBMTx05wZZXzjS99w5gNQ5NIlUgXxJHADFkAKzayMVbWC5gFr2qcldJEhj8hrWyRpU8JBRMjrYxS4YQU_b4xsXLKD-MEgCH3hekQUc-ethXPOZbb-KrrgLZzXU26xknHZpj0Dulu1C5Koo_bFGS9NHSdxQp2V4Mruk0x_JtimlfWI9d9nTPt6z9WeIeojeZvL8m_dLpXr17d9APgEwBe1Fcd8mpzG-wLbhqZLF2sUYYHMoKPZnGDTISsh_DhfIMMpoSxAMmVOmS3fHs248zCUEEXwbP__3_PyT2GgKsIENwjrdVynb4AuLiKX5Lt7vc-HMNpCEc1hOvSQMD53eF48ukn3ZVukw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJz5eEJSvwgAjwQTS0qWO4yQPCJWx0bK1qkaH-mYcJ646oXQ07VD5S_gr-Bu5y0fDA-t42Wvis6vc-XxX3-93hLz0tfZ4qBzLOMJY3GGxpVwVWcYoriI_FE7GM9vri84J_zRyRxvkd4mFwbLK0idmjjqaavyPfBcyEaTKClr-u7PvFnaNwtvVsoVGbhaH8fIHpGzp2-4H0O8rxg72h3sdq-gqYGk4veeWKyIVhoY7vvaNrWxhK8a056lI-JEwbhhwBGvCuakDHWKTN5dpcPDKaCFUoByY9xrZ5IhorZHN9_v9wXFVVOJkrUQgseEWb9mjCjO0e9o8Vxovy7GeTDSxpIzxi07Di6Ld7NQ7uENuF-Eqbef2dZdsxEmdXM8bWC7r5EavuJqvk-1BToK93KHDCtOV7tBtOqjosUGm_gUrcDIYMC3F75FfexUNOVUFUwqdGjrJu6j8VLT9uuP02Rt6PpktUopks-Mx7ptkklAEjGLRE-2OP9J0EWpMCmCeCB606SwvBI5TmI2W8PXsbUY_AgOxU_pfS-XfMDPa--TkSvT7gNSSaRI_IhS8mdAiiLnhgrdaSoW-8W0vjCAGdWyuGoSX2pO6oFTHzh7fZFk7dyoLpUtUOj4GpTdIcyV2lnOKXCYgStOQJWAWXLyEU-8yQe9fgnFaOKpUtmTKpC0_21lgbI8gPEdGxaBB_JVkEYvlMdb_LLpVWq-s1llt3wZ5sXoNrgzvp1QSTxc4xnFFAPk5XzMmQIJFyNHXjEH0GXORx6lBHua7Z_Wdmef5sIT7eP2PfE5udoa9I3nU7R8-IbcYxnJZ7eEWqc1ni_gpRKLz8Fmx_Sn5etUe5w9Gy5zU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEBMvCMqtMMBIMIG0tKntOMkDQtVGWRmrKrFNfTOOE1edUDqadqj8En4Lv45zcml4YB0ve0187CrnXp_zHUJeBcb4ItLcsVxaR3CWONrTsWOtFjoOIslznNmjgTw4EZ9G3miD_K56YbCssrKJuaGOpwb_I29DJoJQWWEnaNuyLGK433t__t3BCVJ401qN0yhE5DBZ_oD0LXvX3wdev2as9-F478ApJww4Bjz53PFkrKPICh6YwLrala5mzPi-jmUQS-tFocDGTfChJjQRDnzzmAFjr62RUoeaw743yE2fQ1QFuuSP_Lq8hOdDRSDFEY7ouKO6e6h91rrQBq_NsbJMtrC4jInL_OJlcW_u_3p3yZ0ycKXdQtLukY0kbZBbxSjLZYNsHZWX9A2yMyzgsJe79Lju7sp26Q4d1kDZQNM4xVqcvCGYVuT3ya-9GpCc6hIzhU4tnRTzVH5q2n1zwAfsLb2YzBYZRdjZ8Rg1KJ2kFFtHsfyJ9scfabaIDKYHsE8MD7p0VpQEJxnsRqtG9vxtDkQCC3Fm-l9HFd8wF98H5ORauPuQbKbTNHlMKNg1aWSYCCuk6HS0jgIbuH4UQzTKXaGbRFTcU6YEV8cZH99UVUV3pkqmK2Q6PgamN0lrRXZeoItcRSAr0VBV6ywYewX-7ypC_1-ESVaarEx1VMaUq764eYjsjiBQR2zFsEmCFWUZlRXR1v8cul1Jr6rPWSlyk7xcvQajhjdVOk2mC1zDPRlCpi7WrAkRahGy9TVrsA-NeYjo1CSPCu1ZfWfm-wEc4T1Z_yNfkC2wM-pzf3D4lNxmGNTlRYjbZHM-WyTPICSdR89z3afk63Ubmz-UfZ-b |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparative+analysis+of+influenza+A%28H3N2%29+virus+hemagglutinin+specific+IgG+subclass+and+IgA+responses+in+children+and+adults+after+influenza+vaccination&rft.jtitle=Vaccine&rft.au=Manenti%2C+Alessandro&rft.au=Tete%2C+Sarah+M.&rft.au=Mohn%2C+Kristin+G.-I.&rft.au=Jul-Larsen%2C+%C3%85sne&rft.date=2017-01-03&rft.pub=Elsevier+Ltd&rft.issn=0264-410X&rft.volume=35&rft.issue=1&rft.spage=191&rft.epage=198&rft_id=info:doi/10.1016%2Fj.vaccine.2016.10.024&rft.externalDocID=S0264410X16309409 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X16X00539%2Fcov150h.gif |